Janux Therapeutics (JANX) FCF Margin (QoQ) (2021 - 2024)

Janux Therapeutics (JANX) FCF Margin (QoQ) (2021 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Janux Therapeutics 985.11 Mn 985.11 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 -33,755.00
Jun 30, 2024 108,710.00
Mar 31, 2024 -77,756.00
Dec 31, 2023 5,356.00
Sep 30, 2023 101,913.00
Jun 30, 2023 -80,277.00
Mar 31, 2023 -26,343.00
Dec 31, 2022 25,984.00
Sep 30, 2022 -37,051.00
Jun 30, 2022 43,096.00
Mar 31, 2022 -8,586.00
Dec 31, 2021 -16,702.00
Sep 30, 2021 83,812.00
Jun 30, 2021 -279,922.00